Inova Translational Medicine Institute
Heart Transplant Cell-Free DNA Test Enables Earlier Detection of Acute Rejection Than Biopsy
Premium
The researchers hope that donor-derived cell-free DNA testing to monitor rejection can help relieve racial disparities in heart transplant outcomes.
Ovarian Cancer Omics Consortium Receives $500K DoD Grant for Early Detection Biomarker Discovery
The consortium is comprised of researchers from Inova, Roswell Park Comprehensive Cancer Center, the Mayo Clinic, and MD Anderson Cancer Center.
Inova Decides to End PGx Test Offerings in Response to FDA Warning Letter
How labs — including those that are part of other healthcare systems — offering PGx testing will react to Inova's decision to not engage with the FDA remains to be seen.
FDA Warning Letter to Inova Raises Questions About Agency Overreach Into Practice of Medicine
Premium
Pharmacogenetics and legal experts took particular issue with the agency's suggestion that "established" drug/gene relationships are found only in FDA-approved drug labels.
FDA Warns Inova to Stop Performing MediMap Tests Without Proper Regulatory Approvals
The agency said the MediMap tests are in violation of Federal Food, Drug, and Cosmetic Act because they are intended, in part, for use in disease diagnosis.